Fludarabine treatment in B-cell chronic lymphocytic leukemia: response, toxicity and survival analysis in 47 cases.

Stelitano, C; Morabito, F; Kropp, M G; Callea, V; Iuliano, F; Oriana, V; Levato, D; Nobile, F; Molica, S; Brugiatelli, M

Stelitano, C; Morabito, F; Kropp, M G; Callea, V; Iuliano, F; Oriana, V; Levato, D; Nobile, F; Molica, S; Brugiatelli, M.

Affiliation

Stelitano C; Dipartimento di Emato-Oncologia, Azienda Ospedaliera Bianchi-Melacrino-Morelli, 89100 Reggio Calabria, Italy. morctmo@tin.it

Haematologica ; 84(4): 317-23, 1999 Apr.

Article de En | MEDLINE | ID: mdl-10190945

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vidarabine / Leucémie chronique lymphocytaire à cellules B / Antinéoplasiques Type d'étude: Clinical_trials Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Haematologica Année: 1999 Type de document: Article Pays d'affiliation: Italie Pays de publication: Italie

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links